Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 517

1.

Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction.

Torrieri G, Fontana F, Figueiredo P, Liu Z, Ferreira MPA, Talman V, Martins JP, Fusciello M, Moslova K, Teesalu T, Cerullo V, Hirvonen J, Ruskoaho H, Balasubramanian V, Santos HA.

Nanoscale. 2020 Jan 13. doi: 10.1039/c9nr09934d. [Epub ahead of print]

PMID:
31930241
2.

Dissociable neural systems for unconditioned acute and sustained fear.

Hudson M, Seppälä K, Putkinen V, Sun L, Glerean E, Karjalainen T, Karlsson HK, Hirvonen J, Nummenmaa L.

Neuroimage. 2020 Jan 8:116522. doi: 10.1016/j.neuroimage.2020.116522. [Epub ahead of print]

3.

Artificially cloaked viral nanovaccine for cancer immunotherapy.

Fusciello M, Fontana F, Tähtinen S, Capasso C, Feola S, Martins B, Chiaro J, Peltonen K, Ylösmäki L, Ylösmäki E, Hamdan F, Kari OK, Ndika J, Alenius H, Urtti A, Hirvonen JT, Santos HA, Cerullo V.

Nat Commun. 2019 Dec 17;10(1):5747. doi: 10.1038/s41467-019-13744-8.

4.

Microfluidics for Production of Particles: Mechanism, Methodology, and Applications.

Liu Z, Fontana F, Python A, Hirvonen JT, Santos HA.

Small. 2019 Nov 8:e1904673. doi: 10.1002/smll.201904673. [Epub ahead of print] Review.

PMID:
31702878
5.

Engineered antibody-functionalized porous silicon nanoparticles for therapeutic targeting of pro-survival pathway in endogenous neuroblasts after stroke.

Balasubramanian V, Domanskyi A, Renko JM, Sarparanta M, Wang CF, Correia A, Mäkilä E, Alanen OS, Salonen J, Airaksinen AJ, Tuominen R, Hirvonen J, Airavaara M, Santos HA.

Biomaterials. 2020 Jan;227:119556. doi: 10.1016/j.biomaterials.2019.119556. Epub 2019 Oct 18.

6.

Effect of Phytase on in Vitro Hydrolysis of Phytate and the Formation of myo-Inositol Phosphate Esters in Various Feed Materials.

Hirvonen J, Liljavirta J, Saarinen MT, Lehtinen MJ, Ahonen I, Nurminen P.

J Agric Food Chem. 2019 Oct 16;67(41):11396-11402. doi: 10.1021/acs.jafc.9b03919. Epub 2019 Oct 3.

PMID:
31537068
7.

The effect of 2'-fucosyllactose on simulated infant gut microbiome and metabolites; a pilot study in comparison to GOS and lactose.

Salli K, Anglenius H, Hirvonen J, Hibberd AA, Ahonen I, Saarinen MT, Tiihonen K, Maukonen J, Ouwehand AC.

Sci Rep. 2019 Sep 13;9(1):13232. doi: 10.1038/s41598-019-49497-z.

8.

Correction to "Targeted Reinforcement of Macrophage Reprogramming Toward M2 Polarization by IL-4-Loaded Hyaluronic Acid Particles".

Shahbazi MA, Sedighi M, Bauleth-Ramos T, Kant K, Correia A, Poursina N, Sarmento B, Hirvonen J, Santos HA.

ACS Omega. 2019 Mar 28;4(3):5931. doi: 10.1021/acsomega.9b00668. eCollection 2019 Mar 31.

9.

Targeted Reinforcement of Macrophage Reprogramming Toward M2 Polarization by IL-4-Loaded Hyaluronic Acid Particles.

Shahbazi MA, Sedighi M, Bauleth-Ramos T, Kant K, Correia A, Poursina N, Sarmento B, Hirvonen J, Santos HA.

ACS Omega. 2018 Dec 27;3(12):18444-18455. doi: 10.1021/acsomega.8b03182. eCollection 2018 Dec 31. Erratum in: ACS Omega. 2019 Mar 28;4(3):5931.

10.

Prevalence of thoracic aortic aneurysms and dilatations in patients with intracranial aneurysms.

Laukka D, Pan E, Fordell T, Alpay K, Rahi M, Hirvonen J, Rinne J, Gunn J.

J Vasc Surg. 2019 Dec;70(6):1801-1808. doi: 10.1016/j.jvs.2019.01.066. Epub 2019 Jul 18.

PMID:
31327605
11.

Novel Genes and Metabolite Trends in Bifidobacterium longum subsp. infantis Bi-26 Metabolism of Human Milk Oligosaccharide 2'-fucosyllactose.

Zabel B, Yde CC, Roos P, Marcussen J, Jensen HM, Salli K, Hirvonen J, Ouwehand AC, Morovic W.

Sci Rep. 2019 May 28;9(1):7983. doi: 10.1038/s41598-019-43780-9.

12.

Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor.

Fontana F, Fusciello M, Groeneveldt C, Capasso C, Chiaro J, Feola S, Liu Z, Mäkilä EM, Salonen JJ, Hirvonen JT, Cerullo V, Santos HA.

ACS Nano. 2019 Jun 25;13(6):6477-6490. doi: 10.1021/acsnano.8b09613. Epub 2019 May 17.

13.

Preparation and Characterization of Dentin Phosphophoryn-Derived Peptide-Functionalized Lignin Nanoparticles for Enhanced Cellular Uptake.

Figueiredo P, Sipponen MH, Lintinen K, Correia A, Kiriazis A, Yli-Kauhaluoma J, Österberg M, George A, Hirvonen J, Kostiainen MA, Santos HA.

Small. 2019 Jun;15(24):e1901427. doi: 10.1002/smll.201901427. Epub 2019 May 6.

PMID:
31062448
14.

Automatic real-time uncertainty estimation for online measurements: a case study on water turbidity.

Kahiluoto J, Hirvonen J, Näykki T.

Environ Monit Assess. 2019 Apr 2;191(5):259. doi: 10.1007/s10661-019-7374-7.

15.

Evaluation of two tuberculosis PCR assays for routine use in a clinical setting of low population and low tuberculosis prevalence.

Luukinen BV, Vuento R, Hirvonen JJ.

APMIS. 2019 Jun;127(6):462-467. doi: 10.1111/apm.12947. Epub 2019 Apr 11.

PMID:
30901113
16.

Intranasal naloxone rapidly occupies brain mu-opioid receptors in human subjects.

Johansson J, Hirvonen J, Lovró Z, Ekblad L, Kaasinen V, Rajasilta O, Helin S, Tuisku J, Sirén S, Pennanen M, Agrawal A, Crystal R, Vainio PJ, Alho H, Scheinin M.

Neuropsychopharmacology. 2019 Aug;44(9):1667-1673. doi: 10.1038/s41386-019-0368-x. Epub 2019 Mar 13.

PMID:
30867551
17.

Pharmacy Practice and Education in Finland.

Hirvonen J, Salminen O, Vuorensola K, Katajavuori N, Huhtala H, Atkinson J.

Pharmacy (Basel). 2019 Feb 23;7(1). pii: E21. doi: 10.3390/pharmacy7010021.

18.

Microfluidic Nanoassembly of Bioengineered Chitosan-Modified FcRn-Targeted Porous Silicon Nanoparticles @ Hypromellose Acetate Succinate for Oral Delivery of Antidiabetic Peptides.

Martins JP, Liu D, Fontana F, Ferreira MPA, Correia A, Valentino S, Kemell M, Moslova K, Mäkilä E, Salonen J, Hirvonen J, Sarmento B, Santos HA.

ACS Appl Mater Interfaces. 2018 Dec 26;10(51):44354-44367. doi: 10.1021/acsami.8b20821. Epub 2018 Dec 17.

PMID:
30525379
19.

Comparison of three multiplex real-time PCR assays for detection of enteric viruses in patients with diarrhea.

Hirvonen JJ.

Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):241-244. doi: 10.1007/s10096-018-3418-0. Epub 2018 Nov 9.

PMID:
30414091
20.

Dynamic large-scale network synchronization from perception to action.

Hirvonen J, Monto S, Wang SH, Palva JM, Palva S.

Netw Neurosci. 2018 Oct 1;2(4):442-463. doi: 10.1162/netn_a_00039. eCollection 2018.

21.

Hierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine.

Li W, Li Y, Liu Z, Kerdsakundee N, Zhang M, Zhang F, Liu X, Bauleth-Ramos T, Lian W, Mäkilä E, Kemell M, Ding Y, Sarmento B, Wiwattanapatapee R, Salonen J, Zhang H, Hirvonen JT, Liu D, Deng X, Santos HA.

Biomaterials. 2018 Dec;185:322-332. doi: 10.1016/j.biomaterials.2018.09.024. Epub 2018 Sep 19.

22.

High-Generation Amphiphilic Janus-Dendrimers as Stabilizing Agents for Drug Suspensions.

Selin M, Nummelin S, Deleu J, Ropponen J, Viitala T, Lahtinen M, Koivisto J, Hirvonen J, Peltonen L, Kostiainen MA, Bimbo LM.

Biomacromolecules. 2018 Oct 8;19(10):3983-3993. doi: 10.1021/acs.biomac.8b00931. Epub 2018 Sep 12.

23.

Brain neurokinin-1 receptor availability in never-medicated patients with major depression - A pilot study.

Nyman M, Eskola O, Kajander J, Jokinen R, Penttinen J, Karjalainen T, Nummenmaa L, Hirvonen J, Burns D, Hargreaves R, Solin O, Hietala J.

J Affect Disord. 2019 Jan 1;242:188-194. doi: 10.1016/j.jad.2018.08.084. Epub 2018 Aug 25.

PMID:
30193189
24.

Impact of Pore Size and Surface Chemistry of Porous Silicon Particles and Structure of Phospholipids on Their Interactions.

Liu D, Lipponen K, Quan P, Wan X, Zhang H, Mäkilä E, Salonen J, Kostiainen R, Hirvonen J, Kotiaho T, Santos HA.

ACS Biomater Sci Eng. 2018 Jul 9;4(7):2308-2313. doi: 10.1021/acsbiomaterials.8b00343. Epub 2018 Jun 14.

25.

Decreased Cannabinoid CB1 Receptors in Male Tobacco Smokers Examined With Positron Emission Tomography.

Hirvonen J, Zanotti-Fregonara P, Gorelick DA, Lyoo CH, Rallis-Frutos D, Morse C, Zoghbi SS, Pike VW, Volkow ND, Huestis MA, Innis RB.

Biol Psychiatry. 2018 Nov 15;84(10):715-721. doi: 10.1016/j.biopsych.2018.07.009. Epub 2018 Jul 21.

26.

Aerobic exercise modulates anticipatory reward processing via the μ-opioid receptor system.

Saanijoki T, Nummenmaa L, Tuulari JJ, Tuominen L, Arponen E, Kalliokoski KK, Hirvonen J.

Hum Brain Mapp. 2018 Oct;39(10):3972-3983. doi: 10.1002/hbm.24224. Epub 2018 Jun 8.

PMID:
29885086
27.

Engineered Multifunctional Albumin-Decorated Porous Silicon Nanoparticles for FcRn Translocation of Insulin.

Martins JP, D'Auria R, Liu D, Fontana F, Ferreira MPA, Correia A, Kemell M, Moslova K, Mäkilä E, Salonen J, Casettari L, Hirvonen J, Sarmento B, Santos HA.

Small. 2018 Jul;14(27):e1800462. doi: 10.1002/smll.201800462. Epub 2018 May 31.

PMID:
29855134
28.

Production of pure drug nanocrystals and nano co-crystals by confinement methods.

Fontana F, Figueiredo P, Zhang P, Hirvonen JT, Liu D, Santos HA.

Adv Drug Deliv Rev. 2018 Jun;131:3-21. doi: 10.1016/j.addr.2018.05.002. Epub 2018 May 5. Review.

PMID:
29738786
29.

μ-opioid receptor system mediates reward processing in humans.

Nummenmaa L, Saanijoki T, Tuominen L, Hirvonen J, Tuulari JJ, Nuutila P, Kalliokoski K.

Nat Commun. 2018 Apr 16;9(1):1500. doi: 10.1038/s41467-018-03848-y.

30.

Cannabinoid Type 1 Receptors Are Upregulated During Acute Activation of Brown Adipose Tissue.

Lahesmaa M, Eriksson O, Gnad T, Oikonen V, Bucci M, Hirvonen J, Koskensalo K, Teuho J, Niemi T, Taittonen M, Lahdenpohja S, U Din M, Haaparanta-Solin M, Pfeifer A, Virtanen KA, Nuutila P.

Diabetes. 2018 Jul;67(7):1226-1236. doi: 10.2337/db17-1366. Epub 2018 Apr 12.

31.

Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4-NKX2-5 Interaction.

Kinnunen SM, Tölli M, Välimäki MJ, Gao E, Szabo Z, Rysä J, Ferreira MPA, Ohukainen P, Serpi R, Correia A, Mäkilä E, Salonen J, Hirvonen J, Santos HA, Ruskoaho H.

Sci Rep. 2018 Mar 15;8(1):4611. doi: 10.1038/s41598-018-22830-8.

32.

Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy.

Li W, Liu Z, Fontana F, Ding Y, Liu D, Hirvonen JT, Santos HA.

Adv Mater. 2018 Jun;30(24):e1703740. doi: 10.1002/adma.201703740. Epub 2018 Mar 13. Review.

PMID:
29534311
33.

Simultaneous PET-MRI Confirms That Cerebral Blood Flow Does Not Confound PET Neuroreceptor Activation Studies.

Nummenmaa L, Tuominen L, Hirvonen J.

ACS Chem Neurosci. 2018 Feb 21;9(2):159-161. doi: 10.1021/acschemneuro.7b00489. Epub 2018 Jan 5.

PMID:
29303246
34.

Drug nanocrystals - Versatile option for formulation of poorly soluble materials.

Peltonen L, Hirvonen J.

Int J Pharm. 2018 Feb 15;537(1-2):73-83. doi: 10.1016/j.ijpharm.2017.12.005. Epub 2017 Dec 17.

PMID:
29262301
35.

Conductive vancomycin-loaded mesoporous silica polypyrrole-based scaffolds for bone regeneration.

Zanjanizadeh Ezazi N, Shahbazi MA, Shatalin YV, Nadal E, Mäkilä E, Salonen J, Kemell M, Correia A, Hirvonen J, Santos HA.

Int J Pharm. 2018 Jan 30;536(1):241-250. doi: 10.1016/j.ijpharm.2017.11.065. Epub 2017 Nov 28.

PMID:
29195917
36.

Whole-Brain Source-Reconstructed MEG-Data Reveal Reduced Long-Range Synchronization in Chronic Schizophrenia.

Hirvonen J, Wibral M, Palva JM, Singer W, Uhlhaas P, Palva S.

eNeuro. 2017 Oct 17;4(5). pii: ENEURO.0338-17.2017. doi: 10.1523/ENEURO.0338-17.2017. eCollection 2017 Sep-Oct.

37.

Multifunctional Nanohybrid Based on Porous Silicon Nanoparticles, Gold Nanoparticles, and Acetalated Dextran for Liver Regeneration and Acute Liver Failure Theranostics.

Liu Z, Li Y, Li W, Xiao C, Liu D, Dong C, Zhang M, Mäkilä E, Kemell M, Salonen J, Hirvonen JT, Zhang H, Zhou D, Deng X, Santos HA.

Adv Mater. 2018 Jun;30(24):e1703393. doi: 10.1002/adma.201703393. Epub 2017 Oct 11.

PMID:
29024054
38.

Neuroticism Associates with Cerebral in Vivo Serotonin Transporter Binding Differently in Males and Females.

Tuominen L, Miettunen J, Cannon DM, Drevets WC, Frokjaer VG, Hirvonen J, Ichise M, Jensen PS, Keltikangas-Järvinen L, Klaver JM, Knudsen GM, Takano A, Suhara T, Hietala J.

Int J Neuropsychopharmacol. 2017 Dec 1;20(12):963-970. doi: 10.1093/ijnp/pyx071.

39.

Competence-Based Pharmacy Education in the University of Helsinki.

Katajavuori N, Salminen O, Vuorensola K, Huhtala H, Vuorela P, Hirvonen J.

Pharmacy (Basel). 2017 Jun 1;5(2). pii: E29. doi: 10.3390/pharmacy5020029.

40.

The Second Round of the PHAR-QA Survey of Competences for Pharmacy Practice.

Atkinson J, De Paepe K, Pozo AS, Rekkas D, Volmer D, Hirvonen J, Bozic B, Skowron A, Mircioiu C, Marcincal A, Koster A, Wilson K, van Schravendijk C.

Pharmacy (Basel). 2016 Sep 21;4(3). pii: E27. doi: 10.3390/pharmacy4030027.

41.

Functionalization of carboxylated lignin nanoparticles for targeted and pH-responsive delivery of anticancer drugs.

Figueiredo P, Ferro C, Kemell M, Liu Z, Kiriazis A, Lintinen K, Florindo HF, Yli-Kauhaluoma J, Hirvonen J, Kostiainen MA, Santos HA.

Nanomedicine (Lond). 2017 Nov;12(21):2581-2596. doi: 10.2217/nnm-2017-0219. Epub 2017 Sep 29.

PMID:
28960138
42.

Current developments and applications of microfluidic technology toward clinical translation of nanomedicines.

Liu D, Zhang H, Fontana F, Hirvonen JT, Santos HA.

Adv Drug Deliv Rev. 2018 Mar 15;128:54-83. doi: 10.1016/j.addr.2017.08.003. Epub 2017 Aug 8. Review.

PMID:
28801093
43.

Accuracy of 837 pedicle screw positions in degenerative lumbar spine with conventional open surgery evaluated by computed tomography.

Saarenpää I, Laine T, Hirvonen J, Hurme S, Kotilainen E, Rinne J, Korhonen K, Frantzén J.

Acta Neurochir (Wien). 2017 Oct;159(10):2011-2017. doi: 10.1007/s00701-017-3289-7. Epub 2017 Aug 10.

PMID:
28799104
44.

Erratum. Weight Loss After Bariatric Surgery Reverses Insulin-Induced Increases in Brain Glucose Metabolism of the Morbidly Obese. Diabetes 2013;62:2747-2751.

Tuulari JJ, Karlsson HK, Hirvonen J, Hannukainen JC, Bucci M, Helmiö M, Ovaska J, Soinio M, Salminen P, Savisto N, Nummenmaa L, Nuutila P.

Diabetes. 2017 Oct;66(10):2724. doi: 10.2337/db17-er10a. Epub 2017 Aug 1. No abstract available.

45.

Feeding Releases Endogenous Opioids in Humans.

Tuulari JJ, Tuominen L, de Boer FE, Hirvonen J, Helin S, Nuutila P, Nummenmaa L.

J Neurosci. 2017 Aug 23;37(34):8284-8291. doi: 10.1523/JNEUROSCI.0976-17.2017. Epub 2017 Jul 26.

46.

Opioid Release after High-Intensity Interval Training in Healthy Human Subjects.

Saanijoki T, Tuominen L, Tuulari JJ, Nummenmaa L, Arponen E, Kalliokoski K, Hirvonen J.

Neuropsychopharmacology. 2018 Jan;43(2):246-254. doi: 10.1038/npp.2017.148. Epub 2017 Jul 19.

47.

Multifunctional Nanotube-Mucoadhesive Poly(methyl vinyl ether-co-maleic acid)@Hydroxypropyl Methylcellulose Acetate Succinate Composite for Site-Specific Oral Drug Delivery.

Kerdsakundee N, Li W, Martins JP, Liu Z, Zhang F, Kemell M, Correia A, Ding Y, Airavaara M, Hirvonen J, Wiwattanapatapee R, Santos HA.

Adv Healthc Mater. 2017 Oct;6(20). doi: 10.1002/adhm.201700629. Epub 2017 Jul 17.

PMID:
28714596
48.

Drug-Loaded Multifunctional Nanoparticles Targeted to the Endocardial Layer of the Injured Heart Modulate Hypertrophic Signaling.

Ferreira MPA, Ranjan S, Kinnunen S, Correia A, Talman V, Mäkilä E, Barrios-Lopez B, Kemell M, Balasubramanian V, Salonen J, Hirvonen J, Ruskoaho H, Airaksinen AJ, Santos HA.

Small. 2017 Sep;13(33). doi: 10.1002/smll.201701276. Epub 2017 Jul 17.

PMID:
28714245
49.

Comparison of liposomal drug formulations for transdermal iontophoretic drug delivery.

Malinovskaja-Gomez K, Espuelas S, Garrido MJ, Hirvonen J, Laaksonen T.

Eur J Pharm Sci. 2017 Aug 30;106:294-301. doi: 10.1016/j.ejps.2017.06.025. Epub 2017 Jun 15.

PMID:
28625748
50.

Bridging the Knowledge of Different Worlds to Understand the Big Picture of Cancer Nanomedicines.

Balasubramanian V, Liu Z, Hirvonen J, Santos HA.

Adv Healthc Mater. 2018 Jan;7(1). doi: 10.1002/adhm.201700432. Epub 2017 Jun 1. Review.

PMID:
28570787

Supplemental Content

Loading ...
Support Center